DNA VIRUS VACCINE AGAINST FELINE IMMUNODEFICIENCY VIRUS

PROBLEM TO BE SOLVED: To obtain a composition for a vaccine against feline immunodeficiency virus(FIV) and for diagnosing this disease by mixing an immunologically effective amount of a nucleotide which is a part of a genome of FIV and a carrier and so on. SOLUTION: A vaccine composition is obtained...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MARK BRIAN ROSS, REITAN TON, WILLIAM D KOERUTOOJE, ANTHONY FAY JOHNSON, TERESITA DORARESU YUURU, ERIK DOUGLAS FO, SURESH JEBARASANAN, DAVID WALTER WHEELER, SHEPPARD MICHAEL GEORGE
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To obtain a composition for a vaccine against feline immunodeficiency virus(FIV) and for diagnosing this disease by mixing an immunologically effective amount of a nucleotide which is a part of a genome of FIV and a carrier and so on. SOLUTION: A vaccine composition is obtained which is useful for treating and diagnosing feline immunodeficiency virus(FIV) infection in the field of animal health by mixing an immunologically effective amount of nucleotide(s) selected from a part of a genome coding for GAG, MA, CA, NC, and ENV polyproteins, SV and TM structural proteins, POL proteins, PR, RT, DV, IN, Rev, Vif, and ORF2 non-structural proteins from FIV, a combination of these, or its degenerate variant nucleotide and a veterinarily acceptable carrier.